You are here:

corifollitropin alfa (Elonva)

Advice

in the absence of a submission from the holder of the marketing authorisation:

corifollitropin alfa (Elonva ®) is not recommended for use within NHSScotland for the treatment of Controlled Ovarian Stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an Assisted Reproductive Technology (ART) program.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: corifollitropin alfa (Elonva)
SMC Drug ID: 633/10
Manufacturer: MSD
Indication: for the treatment of Controlled Ovarian Stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an Assisted Reproductive Technology (ART) program.
BNF Category:
Sub Category: N/A
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 12 July 2010

Back